So-Yeon Kim

Title: So-Yeon Kim: Innovator in Neovascularization Research

Introduction

So-Yeon Kim is a prominent inventor based in Ulsan, South Korea. She has made significant contributions to the field of biomedical research, particularly in the area of neovascularization. Her innovative work has led to the development of compounds that can inhibit neovascularization factors, which are crucial in treating various diseases.

Latest Patents

So-Yeon Kim holds 1 patent for her invention titled "Compounds for inhibiting neovascularization factors and use thereof." This patent outlines methods for treating neovascularization diseases using the compounds she has developed. Her research is pivotal in advancing therapeutic options for conditions related to abnormal blood vessel growth.

Career Highlights

Throughout her career, So-Yeon Kim has worked with notable organizations, including Smartin Bio Inc. and the Ulsan National Institute of Science and Technology. Her experience in these institutions has allowed her to collaborate with leading experts in her field and contribute to groundbreaking research.

Collaborations

So-Yeon Kim has collaborated with esteemed colleagues such as Changwook Lee and Dong Ho Park. These partnerships have enhanced her research efforts and expanded the impact of her innovations in the scientific community.

Conclusion

So-Yeon Kim's work in developing compounds for inhibiting neovascularization factors showcases her dedication to advancing medical science. Her contributions are vital for the treatment of neovascularization diseases, and her innovative spirit continues to inspire future research in this important area.